143 related articles for article (PubMed ID: 16540317)
1. Human methionine aminopeptidase type 2 in complex with L- and D-methionine.
Nonato MC; Widom J; Clardy J
Bioorg Med Chem Lett; 2006 May; 16(10):2580-3. PubMed ID: 16540317
[TBL] [Abstract][Full Text] [Related]
2. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
Liu S; Widom J; Kemp CW; Crews CM; Clardy J
Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
[TBL] [Abstract][Full Text] [Related]
3. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the functional differences between type I and type II human methionine aminopeptidases.
Addlagatta A; Hu X; Liu JO; Matthews BW
Biochemistry; 2005 Nov; 44(45):14741-9. PubMed ID: 16274222
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of metalloform-selective inhibition of methionine aminopeptidase.
Xie SX; Huang WJ; Ma ZQ; Huang M; Hanzlik RP; Ye QZ
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):425-32. PubMed ID: 16552144
[TBL] [Abstract][Full Text] [Related]
8. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Klein CD; Folkers G
Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the metal binding site in methionine aminopeptidase by density functional theory.
Jørgensen AT; Norrby PO; Liljefors T
J Comput Aided Mol Des; 2002 Mar; 16(3):167-79. PubMed ID: 12363216
[TBL] [Abstract][Full Text] [Related]
10. Cryo-EM Structures Reveal Relocalization of MetAP in the Presence of Other Protein Biogenesis Factors at the Ribosomal Tunnel Exit.
Bhakta S; Akbar S; Sengupta J
J Mol Biol; 2019 Mar; 431(7):1426-1439. PubMed ID: 30753870
[TBL] [Abstract][Full Text] [Related]
11. Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases.
Arya T; Reddi R; Kishor C; Ganji RJ; Bhukya S; Gumpena R; McGowan S; Drag M; Addlagatta A
J Med Chem; 2015 Mar; 58(5):2350-7. PubMed ID: 25699713
[TBL] [Abstract][Full Text] [Related]
12. Disclosing new inhibitors by finding similarities in three-dimensional active-site architectures of polynuclear zinc phospholipases and aminopeptidases.
González-Roura A; Navarro I; Delgado A; Llebaria A; Casas J
Angew Chem Int Ed Engl; 2004 Feb; 43(7):862-5. PubMed ID: 14767959
[No Abstract] [Full Text] [Related]
13. Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.
Addlagatta A; Matthews BW
Protein Sci; 2006 Aug; 15(8):1842-8. PubMed ID: 16823043
[TBL] [Abstract][Full Text] [Related]
14. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R
Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983
[TBL] [Abstract][Full Text] [Related]
15. S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitors.
Poreba M; Gajda A; Picha J; Jiracek J; Marschner A; Klein CD; Salvesen GS; Drag M
Biochimie; 2012 Mar; 94(3):704-10. PubMed ID: 22085501
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2.
Han CK; Ahn SK; Choi NS; Hong RK; Moon SK; Chun HS; Lee SJ; Kim JW; Hong CI; Kim D; Yoon JH; No KT
Bioorg Med Chem Lett; 2000 Jan; 10(1):39-43. PubMed ID: 10636239
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
18. Binding of alpha-hydroxy-beta-amino acid inhibitors to methionine aminopeptidase. The performance of two types of scoring functions.
Jørgensen AT; Sørensen MD; Björkling F; Liljefors T
J Comput Aided Mol Des; 2003; 17(5-6):383-97. PubMed ID: 14635729
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of Ebp1 reveals a methionine aminopeptidase fold as binding platform for multiple interactions.
Kowalinski E; Bange G; Bradatsch B; Hurt E; Wild K; Sinning I
FEBS Lett; 2007 Sep; 581(23):4450-4. PubMed ID: 17765895
[TBL] [Abstract][Full Text] [Related]
20. Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: a critical view of the relevance of in vitro metalloenzyme assays.
Schiffmann R; Heine A; Klebe G; Klein CD
Angew Chem Int Ed Engl; 2005 Jun; 44(23):3620-3. PubMed ID: 15880695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
